Table of Contents

2018-2023 Global Promacta Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Promacta Consumption 2013-2023
  • 2.1.2 Promacta Consumption CAGR by Region
• 2.2 Promacta Segment by Type
  • 2.2.1 25mg
  • 2.2.2 50mg
  • 2.2.3 75mg
• 2.3 Promacta Consumption by Type
  • 2.3.1 Global Promacta Consumption Market Share by Type (2013-2018)
  • 2.3.2 Global Promacta Revenue and Market Share by Type (2013-2018)
  • 2.3.3 Global Promacta Sale Price by Type (2013-2018)
• 2.4 Promacta Segment by Application
  • 2.4.1 Hospital
  • 2.4.2 Drugs Store
  • 2.4.3 Other
• 2.5 Promacta Consumption by Application
  • 2.5.1 Global Promacta Consumption Market Share by Application (2013-2018)
  • 2.5.2 Global Promacta Value and Market Share by Application (2013-2018)
  • 2.5.3 Global Promacta Sale Price by Application (2013-2018)

3 Global Promacta by Players

• 3.1 Global Promacta Sales Market Share by Players
  • 3.1.1 Global Promacta Sales by Players (2016-2018)
  • 3.1.2 Global Promacta Sales Market Share by Players (2016-2018)
• 3.2 Global Promacta Revenue Market Share by Players
  • 3.2.1 Global Promacta Revenue by Players (2016-2018)
  • 3.2.2 Global Promacta Revenue Market Share by Players (2016-2018)
• 3.3 Global Promacta Sale Price by Players
• 3.4 Global Promacta Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Promacta Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Promacta Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Promacta by Regions

• 4.1 Promacta by Regions
  • 4.1.1 Global Promacta Consumption by Regions
  • 4.1.2 Global Promacta Value by Regions
• 4.2 Americas Promacta Consumption Growth
• 4.3 APAC Promacta Consumption Growth
• 4.4 Europe Promacta Consumption Growth
• 4.5 Middle East & Africa Promacta Consumption Growth

5 Americas

• 5.1 Americas Promacta Consumption by Countries
  • 5.1.1 Americas Promacta Consumption by Countries (2013-2018)
  • 5.1.2 Americas Promacta Value by Countries (2013-2018)
• 5.2 Americas Promacta Consumption by Type
• 5.3 Americas Promacta Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Promacta Consumption by Countries
  • 6.1.1 APAC Promacta Consumption by Countries (2013-2018)
  • 6.1.2 APAC Promacta Value by Countries (2013-2018)
• 6.2 APAC Promacta Consumption by Type
• 6.3 APAC Promacta Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Promacta by Countries
  • 7.1.1 Europe Promacta Consumption by Countries (2013-2018)
  • 7.1.2 Europe Promacta Value by Countries (2013-2018)
• 7.2 Europe Promacta Consumption by Type
• 7.3 Europe Promacta Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Promacta by Countries
  • 8.1.1 Middle East & Africa Promacta Consumption by Countries (2013-2018)
  • 8.1.2 Middle East & Africa Promacta Value by Countries (2013-2018)
• 8.2 Middle East & Africa Promacta Consumption by Type
• 8.3 Middle East & Africa Promacta Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.2 Promacta Distributors
• 10.3 Promacta Customer

11 Global Promacta Market Forecast

• 11.1 Global Promacta Consumption Forecast (2018-2023)
• 11.2 Global Promacta Forecast by Regions
  • 11.2.1 Global Promacta Forecast by Regions (2018-2023)
  • 11.2.2 Global Promacta Value Forecast by Regions (2018-2023)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Promacta Forecast by Type
• 11.8 Global Promacta Forecast by Application

12 Key Players Analysis

• 12.1 Novartis
  • 12.1.1 Company Details
  • 12.1.2 Promacta Product Offered
  • 12.1.3 Novartis Promacta Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.1.4 Main Business Overview
  • 12.1.5 Novartis News

...

13 Research Findings and Conclusion

Eltrombopag (rINN, codenamed SB-497115-GR) is a medication that has been developed for certain conditions that lead to thrombocytopenia (abnormally low platelet counts). It is a small molecule agonistof the c-mpl (TpoR) receptor, which is the physiological target of the hormone thrombopoietin.

According to this study, over the next five years the Promacta market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2017. In particular, this report presents the global market share (sales and revenue) of key companies in Promacta business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Promacta market by product type, application, key manufacturers and key regions and countries.

This study considers the Promacta value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2013 to 2018, in Section 2.3; and forecast to 2024 in section 11.7.
25mg
50mg
75mg
Segmentation by application: breakdown data from 2013 to 2018, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Drugs Store
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Novartis
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Promacta consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2024.
To understand the structure of Promacta market by identifying its various subsegments.
Focuses on the key global Promacta manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Promacta with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Promacta submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.